Laimei Pharmaceutical announced that its holding subsidiary Hainan Laimei Medical Devices Co., Ltd. has received two “Medical Device Registration Certificates” issued by the Hainan Drug Administration. The products are medical electronic endoscopic image processors and electronic bronchoscopes, which are valid from November 17, 2025 to November 16, 2030. These two products will be used together to facilitate clinical diagnosis and treatment of patients' conditions. This certification will enrich the company's product range and enhance overall competitiveness, but actual product sales are affected by marketing results, and the specific impact on performance cannot be predicted.

Laimei Pharmaceutical announced that its holding subsidiary Hainan Laimei Medical Devices Co., Ltd. has received two “Medical Device Registration Certificates” issued by the Hainan Drug Administration. The products are medical electronic endoscopic image processors and electronic bronchoscopes, which are valid from November 17, 2025 to November 16, 2030. These two products will be used together to facilitate clinical diagnosis and treatment of patients' conditions. This certification will enrich the company's product range and enhance overall competitiveness, but actual product sales are affected by marketing results, and the specific impact on performance cannot be predicted.